Villareal D T, Holloszy J O, Kohrt W M
Washington University Claude Pepper Older Americans Independence Center, Division of Geriatrics and Gerontology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Clin Endocrinol (Oxf). 2000 Nov;53(5):561-8. doi: 10.1046/j.1365-2265.2000.01131.x.
Dehydroepiandrosterone (DHEA) is a precursor for both oestrogens and androgens. Its marked decline with ageing may influence age-related changes in tissues influenced by sex hormones. The aim of this study was to determine the effects of DHEA replacement on bone mineral density (BMD) and body composition in elderly women and men with low serum DHEA sulphate (DHEAS) levels.
Prospective 6 month trial of oral DHEA replacement, 50 mg/day.
Experimental subjects were 10 women and eight men, aged 73 +/- 1 years. Control subjects were 10 women and eight men, aged 74 +/- 1 years.
BMD, body composition, serum markers of bone turnover, serum lipids and lipoproteins, oral glucose tolerance, serum IGF-I, total serum oestrogens and testosterone.
BMD of the total body and lumbar spine increased (mean +/- SEM; 1.6 +/- 0.6% and 2.5 +/- 0.8%, respectively; both P < or = 0.05), fat mass decreased (- 1.3 +/- 0.4 kg; P < 0.01) and fat-free mass increased (0.9 +/- 0.4 kg; P < or = 0. 05) in response to DHEA replacement. DHEA replacement also resulted in increases in serum IGF-I (from 108 +/- 8 to 143 +/- 7 microg/l; P < 0.01) and total serum testosterone concentrations (from 10.7 +/- 1.2 to 15.6 +/- 1.8 nmol/l in the men and from 2.1 +/- 0.2 to 4.5 +/- 0.4 nmol/l in the women; both P < or = 0.05).
The results provide preliminary evidence that DHEA replacement in those elderly women and men who have very low serum DHEAS levels can partially reverse age-related changes in fat mass, fat-free mass, and BMD, and raise the possibility that increases in IGF-I and/or testosterone play a role in mediating these effects of DHEA.
脱氢表雄酮(DHEA)是雌激素和雄激素的前体。其随着年龄增长而显著下降,可能会影响受性激素影响的组织中与年龄相关的变化。本研究的目的是确定DHEA替代疗法对血清硫酸脱氢表雄酮(DHEAS)水平较低的老年女性和男性的骨矿物质密度(BMD)和身体成分的影响。
口服DHEA替代疗法的前瞻性6个月试验,剂量为50毫克/天。
实验对象为10名女性和8名男性,年龄73±1岁。对照对象为10名女性和8名男性,年龄74±1岁。
BMD、身体成分、骨转换的血清标志物、血脂和脂蛋白、口服葡萄糖耐量、血清胰岛素样生长因子-I(IGF-I)、总血清雌激素和睾酮。
接受DHEA替代治疗后,全身和腰椎的BMD增加(平均值±标准误;分别为1.6±0.6%和2.5±0.8%;P均≤0.05),脂肪量减少(-1.3±0.4千克;P<0.01),去脂体重增加(0.9±0.4千克;P≤0.05)。DHEA替代治疗还导致血清IGF-I升高(从108±8微克/升升至143±7微克/升;P<0.01),男性总血清睾酮浓度升高(从10.7±1.2纳摩尔/升升至15.6±1.8纳摩尔/升,女性从2.1±0.2纳摩尔/升升至4.5±0.4纳摩尔/升;P均≤0.05)。
研究结果提供了初步证据,表明血清DHEAS水平极低的老年女性和男性接受DHEA替代治疗可部分逆转与年龄相关的脂肪量、去脂体重和BMD变化,并增加了IGF-I和/或睾酮升高在介导DHEA这些作用中发挥作用的可能性。